Form 4 for IDXX Idexx Laboratories
Accepted 2023-08-07 00:00:00 ET · period of report 2023-08-03 · accession 0000874716-23-000103 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-08-07 | 2023-08-03 | IDXX | Lane Michael | EVP | S - Sale+OE | $510.00 | -16.0K | 4,034 | -80% | -$8.17M |
| DM | 2023-08-07 | 2023-08-03 | IDXX | Lane Michael | EVP | M - OptEx | $187.47 | +16.0K | 5,546 | New | +$3.00M |
| DM | 2023-08-07 | 2023-08-03 | IDXX | Lane Michael | EVP | M - OptEx | $0.00 | -16.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-03 | S | D | 16,027 | $510.00 | 4,033.99 | D | — | — | (F2) Represents the weighted average price of the shares sold ranging from a low of $510.00 to a high of $510.10 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. |
| 2 | Common | Common Stock | 2023-08-03 | M | A | 7,080 | $206.94 | 20,060.99 | D | — | — | |
| 3 | Common | Common Stock | 2023-08-03 | M | A | 7,435 | $178.26 | 12,980.99 | D | — | — | |
| 4 | Common | Common Stock | 2023-08-03 | M | A | 1,512 | $141.60 | 5,545.99 | D | — | — | (F1) Includes 12 shares purchased under the Issuer's Employee Stock Purchase Plan on June 30, 2023. |
| 5 | Derivative | Incentive Stock Option (right-to-buy) | 2023-08-03 | M | D | 7,080 | $0.00 | 1,286 | D | $206.94 · — to 2029-02-13 | 7,080 Common Stock | (F6) Grant of option to buy 8,366 shares of Issuer common stock that vested in five annual installments beginning February 14, 2020. |
| 6 | Derivative | Incentive Stock Option (right-to-buy) | 2023-08-03 | M | D | 7,435 | $0.00 | 0 | D | $178.26 · — to 2028-02-13 | 7,435 Common Stock | (F5) Grant of option to buy 9,434 shares of Issuer common stock that vested in five annual installments beginning February 14, 2019. |
| 7 | Derivative | Incentive Stock Option (right-to-buy) | 2023-08-03 | M | D | 1,512 | $0.00 | 0 | D | $141.60 · — to 2027-02-13 | 1,512 Common Stock | (F4) Grant of option to buy 10,386 shares of Issuer common stock that vested in five annual installments beginning February 14, 2018. |